New added sugar labeling policy could be sweet news for FDA, consumers
The Food and Drug Administration's (FDA) recently announced a mandatory added sugar labeling policy for packaged foods and beverages, set to take effect between 2020 and 2021.
Latest News
Curio Wellness wants cannabis to be regulated under Federal Food, Drug and Cosmetic Act
Curio Wellness, the market-leading medicinal cannabis company in Maryland, presented a scientifically grounded, patient-focused perspective to de-schedule cannabis and have it regulated under the Food and Drug Administration’s Federal Food, Drug, and Costmetic Act.
Recall on Beckman analyzers affected over 2,000 laboratories
Over 2,000 U.S. laboratories ranging from small hospitals to large medical centers have been affected and notified by the U.S. Food and Drug Administration that the Beckman Coulter DxH 800, DxH 600 and DxH 900 hematology analyzer are now under a Class 1 recall.
U.S. FOOD AND DRUG ADMINISTRATION: FDA puts company on notice for marketing unapproved stem cell products for treating serious conditions
Arizona company claims their products can treat Lyme disease, diabetes, Parkinson’s disease and more, but have not been approved for any use
Pharmacology expert says FDA needs to have more oversight over homeopathic products
The U.S. Food and Drug Administration recently sent letters to companies that produce homeopathic products claiming they were in violation of current good manufacturing practice (CGMP) regulations.
FDA Update: April medical device recalls
Recalls of medical devices occur when a company sees a need to either take corrective action or remove a potentially hazardous device from the market, according to the U.S. Food and Drug Administration.
Doctors support FDA in its claim against 'worthless,' 'hocus pocus' homeopathic drugs
The U.S. Food and Drug Administration sent letters to companies that produce homeopathic products claiming they were in violation of current good manufacturing practice (CGMP) regulations.
FDA warns homeopathic manufacturers about false labeling
Five companies with products considered homeopathic have been found to be in violation of the FDA’s current good manufacturing practice regulations.
23 food, dietary supplement recalls initiated
Food producers carried out 23 food or dietary supplement product recalls over the past month, according to the U.S. Food and Drug Administration.
FDA asked to investigate JUUL’s claims of smoking cessation
The Food and Drug Administration has been asked to investigate the e-cigarette company JUUL and its claims that it helps people to stop smoking.
FDA strengthens warning for prescription insomnia medicines
The U.S. Food and Drug Administration is now requiring its strongest warning to be used on several of the most commonly used prescription insomnia medicines.
7 drugs recalled during April, FDA reports
Seven drugs were recalled in April to protect patients from possible harmful defects associated with the products, the U.S. Food and Drug Administration reported.
U.S. FOOD AND DRUG ADMINISTRATION: Life Rising Corporation Recalls Chinese Herbal Supplements Because of Possible Health Risk
Life Rising Corporation of Willowbrook, IL is recalling Life Rising Holder-W Holder Warmer capsules, Life Rising NECK-ND Neck Clear capsules, and HoliCare Metabolism Cleansing (MET-CLS) tablets because the products have the potential to contain excessive levels of lead.
FDA moves to reduce risks associated with surgical staplers and implantable stables
The Medical Device Safety Action plan outlines the FDA’s mission to protect public health in a more timely and effective way.
New campaign seeks to remove opioids from the home
The Food and Drug Administration is looking to women aged 35-64 to “Remove the Risk” of opioids in the household.
'Stop doing these analyses,' Mercatus Center researcher says ahead of FDA benefit-risk public meeting
The U.S. Food and Drug administration's public meeting in May about the agency's human drug lifecycle benefit-risk activities has already attracted a recommendation from a regulatory and policy researcher: “stop doing these analyses.”
NEUROSIGMA, INC.: Announces FDA Clearance of Monarch eTNS System as First Non-Drug Treatment for Pediatric ADHD
NeuroSigma, Inc., a Los Angeles-based bioelectronics company focused on commercializing Trigeminal Nerve Stimulation (TNS) technology for treating neurological and neuropsychiatric disorders announced that its Monarch® eTNS® System (Monarch) received FDA clearance as a non-drug treatment for attention deficit hyperactivity disorder (ADHD).